dna
recombin
silkworm
baculoviru
bmorf
contain
full
orf
fmdv
obtain
result
indirect
immunofluoresc
assay
ifa
show
bmorf
could
express
effici
bmn
cell
inocul
earli
instar
larva
silkworm
polyprotein
fmdv
could
detect
sandwich
elisa
empti
capsidlik
particl
could
observ
electron
microscop
express
product
silkworm
use
antigen
immun
cattl
specif
antibodi
induc
vaccin
anim
immun
cattl
challeng
virul
fmdv
asia
ixj
strain
two
four
cattl
complet
protect
clinic
symptom
allevi
delay
other
result
suggest
strategi
might
use
develop
new
subunit
fmdv
vaccin
footandmouth
diseas
viru
open
read
frame
silkwormbaculoviru
express
system
immunogen
subunit
vaccin
dna
recombin
silkworm
baculoviru
bmorf
contain
full
orf
fmdv
obtain
result
indirect
immunofluoresc
assay
ifa
show
bmorf
could
express
effici
bmn
cell
inocul
earli
instar
larva
silkworm
polyprotein
fmdv
could
detect
sandwich
elisa
empti
capsidlik
particl
could
observ
electron
microscop
express
product
silkworm
use
antigen
immun
cattl
specif
antibodi
induc
vaccin
anim
immun
cattl
challeng
virul
fmdv
asia
ixj
strain
two
four
cattl
complet
protect
clinic
symptom
allevi
delay
other
result
suggest
strategi
might
use
develop
new
subunit
fmdv
vaccin
footandmouth
diseas
viru
open
read
frame
silkwormbaculoviru
express
system
immunogen
subunit
vaccin
footandmouth
diseas
fmd
contagi
diseas
mammal
caus
sever
econom
loss
suscept
clovenhoof
anim
fmd
viru
fmdv
member
genu
aphthoviru
famili
picornavirida
seven
distinct
serotyp
c
asia
sat
sat
ii
sat
iii
identifi
within
extens
antigen
divers
fmdv
positivesens
rna
genom
approxim
nt
length
contain
untransl
region
singl
open
read
frame
orf
untransl
region
poli
tail
orf
encod
polypeptid
cleav
matur
polypeptid
product
viral
proteinas
vaccin
major
mean
control
fmd
outbreak
develop
countri
current
fmd
vaccin
chemic
inactiv
whole
viru
antigen
although
tradit
inactiv
vaccin
prove
effect
may
lead
new
outbreak
fmd
incomplet
inactiv
fmdv
escap
live
viru
vaccin
product
workshop
thu
urgent
develop
novel
fmd
vaccin
safer
effect
econom
tradit
vaccin
demonstr
empti
capsid
immunogen
viron
impli
empti
capsid
fmdv
could
use
mimic
virion
immunolog
therefor
feasibl
choic
develop
empti
capsid
vaccin
express
product
baculoviru
express
system
gener
consid
well
immunogen
possess
abil
assembl
empti
capsid
silkworm
baculoviru
express
system
sever
advantag
high
yield
recombin
protein
nonpathogen
vertebr
host
product
protein
posttransl
process
similar
mammalian
cell
differ
express
system
dna
vaccin
adenoviru
vector
vaccinia
viru
vector
transgen
plant
use
express
antigen
atyp
otyp
fmdv
produc
empti
capsid
knowledg
research
empti
capsid
type
asia
ever
report
present
paper
viru
like
particl
vlp
fmdv
asia
ixj
strain
well
produc
silkwormbaculoviru
express
system
particl
highli
immunogen
abl
stimul
humor
immun
respons
provid
protect
virul
fmdv
fmdv
asia
ixj
strain
propag
cell
line
isol
preserv
lanzhou
veterinari
research
institut
chines
academi
agricultur
scienc
parent
viru
bmn
cell
line
silkworm
varieti
use
experi
maintain
biotechnolog
research
institut
chines
academi
agricultur
scienc
recombin
viru
maintain
bmn
cell
insect
medium
sigma
supplement
heatinactiv
fetal
bovin
serum
invitrogen
genom
rna
extract
viral
supernat
rneasi
qiagen
use
immedi
cdna
synthesi
cdna
synthes
amv
revers
transcriptas
oligo
dt
primer
takara
h
follow
recommend
protocol
pcr
use
amplifi
intact
orf
cdna
use
pair
specif
primer
forward
primer
spe
site
introduc
revers
primer
site
introduc
optim
thermal
program
one
cycl
templat
denatur
min
cycl
denatur
anneal
extens
min
follow
one
cycl
final
extens
min
size
pcr
product
verifi
gl
agaros
gel
electrophoresi
purifi
pcr
product
digest
spe
transfer
vector
xba
digest
fragment
ligat
dna
ligas
yield
construct
construct
transform
e
coli
low
salt
lb
plate
amp
select
result
plasmid
name
pvlorf
identifi
use
restrict
enzym
digest
pcr
confirm
perform
sequenc
sequenc
primer
pvlorf
orf
place
control
polyhedrin
promot
baculovir
transfer
plasmid
pvlorf
cotransfect
linear
dna
bmn
cell
liposomemedi
method
use
transfect
reagent
invitrogen
cotransfect
supernat
subject
plaqu
assay
screen
individu
viral
plaqu
pcr
amplif
conduct
examin
whether
orf
incorpor
baculovir
genom
anoth
two
round
purif
pure
viru
clone
bmorf
obtain
express
fmdv
polyprotein
bmn
cell
analyz
immunofluoresc
test
ifat
bmn
cell
cultur
cover
slip
inocul
moi
pfu
bmorf
h
post
infect
hpi
ifat
conduct
analyz
express
fmdv
polyprotein
cell
rins
pb
time
fix
cold
aceton
min
sampl
incub
rabbit
serum
fmdv
min
humid
box
wash
pb
time
stain
fluoresceinconjug
goat
antirabbit
serum
min
cover
slip
coat
glycerin
observ
via
olympu
fluoresc
microscop
bmn
cell
infect
taken
control
earli
silkworm
infect
rearticl
virolog
combin
viru
pfu
per
larva
die
silkworm
haemolymph
collect
ice
store
sandwichelisa
platbottom
plate
costar
coat
rabbit
serum
fmdv
overnight
block
defat
milk
powder
h
plate
wash
time
fmdv
antigen
haemolymph
lysat
infect
silkworm
bmorf
dilut
twofold
serial
incub
h
subsequ
plate
wash
thoroughli
guinea
pig
sera
fmdv
ad
well
plate
incub
min
rabbit
antiguinea
pig
igg
peroxidas
conjug
sigma
dilut
ad
react
h
substrat
h
plu
orthophenylen
diamin
ad
react
min
stop
ad
moll
sulphur
acid
absorb
determin
nm
harvest
silkworm
haemolymph
centrifug
supernat
examin
observ
viral
empti
capsid
sampl
observ
em
magnif
accord
test
protocol
silkworm
haemolymph
lyse
ultrason
cell
debri
remov
centrifug
dilut
supernat
use
produc
vaccin
follow
convent
prepar
method
liquidphas
block
elisa
lpbe
http
perform
determin
antibodi
titer
screen
candid
cattl
accord
standard
method
world
organ
anim
health
offic
intern
desepizooti
oie
vaccin
candid
potenc
lower
hous
diseasesecur
isol
facil
lanzhou
veterinari
research
institut
detect
kit
prepar
lanzhou
veterinari
research
institut
six
cattl
immun
intramuscular
inocul
site
neck
four
cattl
vaccin
mlanim
vaccin
bmorf
two
control
cattl
vaccin
dose
vaccin
cattl
sera
collect
postvaccin
dpv
antibodi
fmdv
detect
lpbe
method
accord
descript
standard
protocol
oie
http
wwwoieintengnormesmmanu
anim
challeng
intraderm
inocul
two
site
tongu
bovin
infecti
dose
bid
asia
ixj
dpv
restrain
anim
care
examin
mouth
feet
postchalleng
dpc
intact
orf
asia
ixj
strain
amplifi
rtpcr
insert
transfer
vector
gener
plasmid
pvlorf
plasmid
verifi
restrict
enzym
analysi
pcr
result
indic
pvlorf
correctli
construct
sequenc
analysi
indic
orf
approxim
kb
contain
full
code
region
baculovir
transfer
plasmid
pvlorf
cotransfect
linear
dna
bmn
cell
posttransfect
supernat
collect
viral
stock
screen
recombin
viru
isol
viru
plaqu
plaqu
assay
cultiv
well
plate
recombin
viru
identifi
via
ad
xgal
everi
well
pcr
amplif
also
conduct
see
whether
orf
incorpor
viral
genom
anoth
round
purif
pure
viru
clone
obtain
express
polyprotein
bmn
cell
analyz
ifat
result
demonstr
bmn
cell
infect
bmorf
could
produc
specif
fluoresc
weak
fluoresc
background
appear
control
cell
figur
indic
polyprotein
express
validli
bmn
cell
die
silkworm
haemolymph
collect
post
infect
correspond
rear
mean
temperatur
sandwichelisa
conduct
evalu
express
antigen
silkworm
result
indic
valu
harvest
haemolymph
silkworm
infect
bmorf
decreas
dilut
rate
increas
good
agreement
variat
posit
control
fmdv
antigen
antigen
express
haemolymph
half
posit
control
cell
vaccin
undetect
neg
control
infect
silkworm
haemolymph
figur
empti
capsidlik
particl
could
observ
haemolymph
diamet
size
nm
figur
structur
absent
haemolymph
infect
ident
particl
confirm
immunomicroscopi
observ
anim
vaccin
vaccin
prepar
express
antigen
lpbeantibodi
titer
determin
follow
lpbe
method
found
four
cattl
vaccin
bmorf
antigen
develop
detect
fmdvantibodi
respons
dpv
antibodi
titer
reach
cattl
contrast
valenc
antibodi
two
control
cattl
vaccin
vaccin
prepar
boost
tabl
anim
challeng
bid
asia
ixj
dpv
mouth
feet
observ
ten
day
evalu
incid
diseas
result
shown
tabl
bovin
vaccin
vaccin
prepar
express
antigen
bmorf
control
b
fmdvspecif
antibodi
titer
report
serum
dilut
lpbe
method
c
lesion
score
number
feet
cattl
exhibit
protect
determin
cattl
take
clinic
sign
fmd
observ
period
dpc
fmdv
serotyp
asia
first
isol
pakistan
epidem
within
southeast
asia
indian
peninsula
dissemin
among
near
east
middl
east
far
east
diseas
broke
china
sinc
simultan
occurr
two
independ
cattl
field
respect
taian
shandong
provinc
wuxi
jiangsu
provinc
epidem
quickli
spread
among
provinc
caus
great
econom
loss
outbreak
attract
consider
public
scientif
concern
made
urgent
need
develop
safer
effect
fmd
vaccin
among
candid
use
develop
subunit
vaccin
vlp
better
choic
number
intermedi
particl
identifi
fmdvinfect
cell
includ
protom
pentam
particl
uncleav
lack
rna
empti
capsid
virion
among
empti
capsid
immunogen
virion
though
mechan
encapsid
matur
clear
provid
us
better
strategi
design
novel
vaccin
zhang
et
al
construct
recombin
adenoviru
contain
polyprotein
code
region
otyp
fmdv
empti
capsid
observ
electronmicroscop
intact
polyprotein
asiaityp
fmdv
bombyx
mori
larva
express
current
research
use
baculoviru
vector
antigen
detect
use
ifa
sandwichelisa
moreov
empti
capsidlik
particl
could
observ
haemolymph
electronmicroscop
thousand
divers
protein
express
success
baculoviru
express
system
mani
advantag
other
exampl
contain
approxim
foreign
gene
without
affect
viral
duplic
assembl
sever
gene
necessari
viral
assembl
could
simultan
insert
vector
produc
vlp
vlp
produc
baculoviru
express
system
found
safe
immunogen
therefor
system
good
candid
produc
vlp
compar
acnpvsf
cell
express
system
silkwormbaculoviru
express
system
advantag
silkworm
larva
use
vivo
express
express
yield
silkworm
haemolymph
could
least
fold
higher
volum
infect
cell
addit
silkworm
contain
pathogen
crossli
infect
vertebr
silkworm
rear
costeffect
per
larva
china
productioncost
one
import
limit
factor
restrict
new
type
subunit
fmd
vaccin
market
studi
even
gene
kb
could
yield
high
level
antigen
haemolymph
express
product
posttransl
process
assembl
well
lead
conclus
feasibl
employ
silkwormbaculoviru
express
system
larg
scale
product
fmd
vaccin
make
vaccin
use
part
control
strategi
fmd
outbreak
singl
inocul
would
requir
induc
protect
vaccin
trial
follow
bovin
potenc
test
protocol
describ
oie
use
vaccin
manufactur
test
tradit
inactiv
fmd
vaccin
modif
test
subunit
vaccin
potenc
four
cattl
vaccin
vaccin
prepar
bmorf
two
control
vaccin
vaccin
prepar
three
week
vaccin
antibodi
level
four
vaccin
cattl
ascens
control
group
remain
low
challeng
virul
homolog
viru
two
bmorf
subunit
vaccin
immun
cattl
consid
protect
two
delay
diseas
eas
clinic
symptom
control
develop
lesion
feet
insid
mouth
third
day
post
infect
sinc
cattl
suscept
clovenhoof
anim
fmdv
challeng
dose
could
bid
vaccin
cattl
hardli
get
ideal
efficaci
adenoviru
vector
vaccin
known
best
protect
effect
keep
vaccin
cattl
vaccin
unaccept
develop
countri
safeti
preserv
problem
antibodi
titer
obvious
differ
anim
experi
might
due
follow
reason
specif
antigen
produc
silkworm
haemolymph
per
millilit
still
lower
contain
tradit
inactiv
vaccin
thu
fail
offer
enough
protect
anim
uneven
distribut
antigen
prepar
process
manual
prepar
like
lead
differ
immun
dosag
anim
although
humor
immun
play
main
role
cours
fmdv
antiinfect
immun
factor
cellular
immun
may
also
play
part
antiviru
immun
overcom
shortcom
enhanc
immun
respons
work
yet
done
improv
quantiti
express
product
concentr
antigen
enhanc
effici
express
system
delet
unnecessari
region
orf
irrespect
synthesi
process
assembl
viral
structur
protein
empti
viral
capsid
introduc
cellular
immun
factor
success
prepar
new
type
fmd
